AstraZeneca is trading at £12,698.00, up +3.24%, after announcing an AI drug-discovery collaboration with insitro.
- Announced October 15, 2026, the collaboration will use AI to develop liver and heart treatments; insitro is eligible for up to approximately $1.46 billion in milestone payments.
- Dow Jones reported shares rose after the deal; defensive healthcare buying and a broader sector rally also supported gains.
- The supplied context labels the price as live trading, though the latest completed session was October 15.